The seroepidemiology of Bordetella pertussis infections: A study of persons ages 1-65 years

Journal of Infectious Diseases

Volumn 173, Issue 5, 1996, Pages 1256-1259

  Cattaneo, Laura A ^a   Reed, George W ^a   Haase, David H ^a   Wills, Morgan J ^a   Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; PERTUSSIS TOXIN;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN EXPERIMENT; INFANT; NORMAL HUMAN; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROEPIDEMIOLOGY; UNITED STATES; VACCINATION;

EID: 0030013422     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.5.1256     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. Resurgence of pertussis - United States, 1993. MMWR 1993;42:952-60.
2. Edwards KM, Dupont WD, Westrich MK, Plummer WD, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994;169:68-76.
3. Manclark CR, Meade BD, Burstyn DG. Serological response to Bordetella pertussis. In: Rose NR, Friedman H, Fahey JL, eds. Manual of clinical laboratory immunology. 3rd ed. Washington, DC: American Society for Microbiology, 1986:388-94.
4. Chambers J, Hastie T, eds. Statistical models in S. New York: Chapman and Hall, 1993.
5. Takayama N, Watanabe H, Fujita I, Minamitani M. Seroepidemiology of pertussis in the Japanese population. Med Microbiol Immunol 1989;178:1-8.
6. Cromer BA, Goydos J, Hackell J, Mezzatesta J, Dekker C, Mortimer EA. Unrecognized pertussis infection in adolescents. Am J Dis Child 1993; 147:575-7.
7. Lambert HJ. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep 1965;80:365-9.
8. Mink CAM, Cherry JD, Christenson P, et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992;14:464-71.
9. Marchant CD, Loughlin AM, Lett SM, et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 1994;169:1297-305.
10. Edwards KM, Decker MD, Halsey NA, et al. Differences in antibody response to whole-cell pertussis vaccines. Pediatrics 1991;88:1019-23.
11. Khelef N, Danve B, Quentin-Millet MJ, Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun 1993;61:486-90.
12. He Q, Viljanen MK, Ölander RM, et al. Antibodies to filamentous hemag-glutinin of Bordetella pertussis and protection against whooping cough in schoolchildren. J Infect Dis 1994;170:705-8.
13. Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990;161:480-6.
14. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J 1988;296:612-4.
15. Granstrom G, Wretlind B, Granstrom M. Diagnostic value of clinical and bacteriologic findings in pertussis. J Infect 1991;22:17-26.